| Neuroprotective effect of SGLT2 inhibitors A Pawlos, M Broncel, E Woźniak, P Gorzelak-Pabiś Molecules 26 (23), 7213, 2021 | 121 | 2021 |
| IL-33 and IL-4 impair barrier functions of human vascular endothelium via different mechanisms M Chalubinski, K Wojdan, E Luczak, P Gorzelak, M Borowiec, A Gajewski, ... Vascular Pharmacology 73, 57-63, 2015 | 58 | 2015 |
| The effect of 7-ketocholesterol and 25-hydroxycholesterol on the integrity of the human aortic endothelial and intestinal epithelial barriers M Chalubinski, K Zemanek, W Skowron, K Wojdan, P Gorzelak, M Broncel Inflammation Research 62, 1015-1023, 2013 | 52 | 2013 |
| New possible pharmacological targets for statins and ezetimibe M Niedzielski, M Broncel, P Gorzelak-Pabiś, E Woźniak Biomedicine & Pharmacotherapy 129, 110388, 2020 | 47 | 2020 |
| COVID-19: direct and indirect mechanisms of statins A Pawlos, M Niedzielski, P Gorzelak-Pabiś, M Broncel, E Woźniak International Journal of Molecular Sciences 22 (8), 4177, 2021 | 46 | 2021 |
| Sleep changes following statin therapy: a systematic review and meta-analysis of randomized placebo-controlled polysomnographic trials M Broncel, P Gorzelak-Pabiś, A Sahebkar, K Serejko, S Ursoniu, J Rysz, ... Archives of Medical Science 11 (5), 915-926, 2015 | 38 | 2015 |
| The protective effect of dabigatran and rivaroxaban on DNA oxidative changes in a model of vascular endothelial damage with oxidized cholesterol E Woźniak, M Broncel, B Bukowska, P Gorzelak-Pabiś International Journal of Molecular Sciences 21 (6), 1953, 2020 | 31 | 2020 |
| The effect of oxidized cholesterol on barrier functions and IL-10 mRNA expression in human intestinal epithelium co-cultured with dendritic cells in the transwell system M Chalubinski, K Wojdan, P Gorzelak, M Borowiec, M Broncel Food and Chemical Toxicology 69, 289-293, 2014 | 29 | 2014 |
| Innate lymphoid cells type 2–emerging immune regulators of obesity and atherosclerosis M Chalubinski, E Luczak, K Wojdan, P Gorzelak-Pabis, M Broncel Immunology Letters 179, 43-46, 2016 | 25 | 2016 |
| Assessment of the mean time in the therapeutic INR range and the SAME-TT2R2 score in patients with atrial fibrillation and cognitive impairment P Gorzelak-Pabiś, S Zyzak, Ł Krewko, M Broncel Polskie Archiwum Medycyny Wewnętrznej 126 (7-8), 2016 | 22 | 2016 |
| Effect of intensive lipid-lowering therapies on cholinesterase activity in patients with coronary artery disease E Pytel, B Bukowska, M Koter-Michalak, M Olszewska-Banaszczyk, ... Pharmacological Reports 69 (1), 150-155, 2017 | 17 | 2017 |
| Single triglyceride-rich meal destabilizes barrier functions and initiates inflammatory processes of endothelial cells P Gorzelak-Pabiś, E Wozniak, K Wojdan, M Chalubinski, M Broncel Journal of Interferon & Cytokine Research 40 (1), 43-53, 2020 | 14 | 2020 |
| Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group M Broncel, P Gorzelak-Pabiś, A Sahebkar, K Serejko, S Ursoniu, J Rysz, ... Sleep changes following statin therapy: a systematic review and meta …, 2015 | 14 | 2015 |
| State of the art paper Comprehensive insight into immune regulatory mechanisms and vascular wall determinants of atherogenesis–emerging perspectives of immunomodulation M Chalubinski, K Wojdan, R Dorantowicz, P Jackowska, P Gorzelak, ... Archives of Medical Science 9 (1), 159-165, 2013 | 14 | 2013 |
| The effect of interleukin-35 on the integrity, ICAM-1 expression and apoptosis of human aortic smooth muscle cells W Skowron, K Zemanek, K Wojdan, P Gorzelak, M Borowiec, M Broncel, ... Pharmacological Reports 67 (2), 376-381, 2015 | 13 | 2015 |
| Euthyroid sick syndrome as a prognostic indicator of COVID-19 pulmonary involvement, associated with poorer disease prognosis and increased mortality M Świstek, M Broncel, P Gorzelak-Pabiś, P Morawski, M Fabiś, E Woźniak Endocrine Practice 28 (5), 494-501, 2022 | 10 | 2022 |
| The effect of lipid-lowering therapies on the pro-inflammatory and anti-inflammatory properties of vascular endothelial cells E Woźniak, M Broncel, M Niedzielski, A Woźniak, P Gorzelak-Pabiś Plos one 18 (2), e0280741, 2023 | 9 | 2023 |
| Cardiovascular risk and response to lipid lowering therapy in patients with HIV infection according to different recommendations A Pawlos, M Broncel, E Wlazłowska, E Jabłonowska, P Gorzelak-Pabiś PloS one 15 (12), e0244675, 2020 | 7 | 2020 |
| Primary splenic angiosarcoma: a very rare and aggressive neoplasm with a poor prognosis P Gorzelak-Pabiś, A Zuszek-Frynas, M Broncel Pol Arch Intern Med 130 (2), 142-144, 2020 | 7 | 2020 |
| Increased plasma concentrations of interleukin 35 in patients with coronary artery disease P Gorzelak-Pabiś, M Chalubinski, K Wojdan, E Luczak, I Duraj, ... Archives of Medical Science 13 (4), 778-784, 2017 | 7 | 2017 |
